US2020116719A1PendingUtilityA1
Method for detecting opioids, opiates, cannabinoids, or benzodiazepines in a sample with a b-glucuronidase enzyme
Assignee: LA PIEDRA BIOTECNOLOGIA SPAPriority: Aug 26, 2016Filed: Nov 4, 2019Published: Apr 16, 2020
Est. expiryAug 26, 2036(~10 yrs left)· nominal 20-yr term from priority
G01N 33/948G01N 2333/924C12Q 1/34G01N 33/9486G01N 30/72C12Y 302/01031G01N 33/56916
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention discloses a highly efficient method for detecting opiods, opiates, cannabinoids, or benzodiazepines present in a sample, comprising the steps of adding to said sample an enzyme with β-glucuronidase activity originated from genus Brachyspira or any mutant derived thereof; incubating the sample with the enzyme; and detecting said opiods, opiates, cannabinoids, or benzodiazepines by means of a suitable technique.
Claims
exact text as granted — not AI-modified1 . A method for detecting opiods, opiates, cannabinoids, or benzodiazepines in a sample, comprising the steps of:
a) providing the sample in which said opiods, opiates, cannabinoids, or benzodiazepines are to be detected; b) adding to said sample an enzyme with β-glucuronidase activity originated from genus Brachyspira or any mutant derived thereof; c) incubating the sample with the enzyme; and d) detecting said opiods, opiates, cannabinoids, or benzodiazepines through any suitable technique.
2 . The method of claim 1 , wherein the sample is a biological sample.
3 . The method of claim 2 , wherein the biological sample is selected from the group consisting of saliva, whole blood, plasma, urine, hair, skin, teeth, soft tissues, meconium and vitreous humor.
4 . The method of claim 1 , wherein the enzyme with β-glucuronidase activity originates from species Brachyspira pilosicoli.
5 . The method of claim 4 , wherein the enzyme with β-glucuronidase activity is selected from the group consisting of:
a) an amino acid sequence comprising the amino acid sequence shown in SEQ.ID.NO. 1;
b) an amino acid sequence sharing at least an 80% of identity with the amino acid sequence defined in a).
6 . The method of claim 1 , wherein the step of incubating the sample with the enzyme is performed for a period between 1 and 30 minutes.
7 . The method of claim 1 , wherein the step of incubating the sample with the enzyme is performed at a temperature range between 20 and 60 degrees Celsius.
8 . The method of claim 1 , wherein the step of incubating the sample with the enzyme is performed at a range of pH between 4.0 and 9.0.
9 . The method of claim 1 , wherein the suitable technique for detecting opiods, opiates, cannabinoids, or benzodiazepines is selected from the group consisting of LC-MS, GC-MS, HPLC-MS, LC-HRMS, HPLC-HRMS, LC-MS-MS, GC-MS-MS and HPLC-MS-MS.Join the waitlist — get patent alerts
Track US2020116719A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.